Literature DB >> 29046319

Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl).

John W McEvoy1,2,3, Khalil Ibrahim2, Thomas S Kickler4, William A Clarke4, Rani K Hasan2, Matthew J Czarny2, Ali R Keramati2, Rakesh R Goli5, Travis P Gratton5, Jeffrey A Brinker2, Matthews Chacko2, Chao-Wei Hwang2, Peter V Johnston2, Julie M Miller2, Jeffrey C Trost2, William R Herzog2, Roger S Blumenthal6,2, David R Thiemann2, Jon R Resar2, Steven P Schulman2.   

Abstract

Entities:  

Keywords:  blood platelets; fentanyl; percutaneous coronary intervention; ticagrelor

Mesh：

Substances：

Year:  2017        PMID： 29046319     DOI： 10.1161/CIRCULATIONAHA.117.031678

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

Review 1.  Risks of Opioids in ST-Elevation Myocardial Infarction: A Review.

Authors:  Anne Henrieke Tavenier; Renicus Suffridus Hermanides; Jan Paul Ottervanger; Peter Gerrit Johannes Ter Horst; Elvin Kedhi; Adriaan W J van 't Hof
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

2.  Comparative effects of fentanyl versus morphine on platelet inhibition induced by ticagrelor in patients with ST-segment elevation myocardial infarction: Full results of the PERSEUS randomized trial.

Authors:  Juan F Iglesias; Marco Valgimigli; Federico Carbone; Nathalie Lauriers; Pier-Giorgio Masci; Sophie Degrauwe
Journal:  Cardiol J       Date:  2022-06-28       Impact factor: 3.487

3.  Old Is (Not) Gold: Midazolam Monotherapy versus Midazolam Plus Fentanyl for Sedation during Cardiac Catheterization.

Authors:  William Black; Raj Baljepally; Laylan Shali; Omar Alsharif; Scott Warden; Eric Heidel; Xiaopeng Zhao
Journal:  J Interv Cardiol       Date:  2021-08-02       Impact factor: 2.279

4.  Fentanyl Delays the Platelet Inhibition Effects of Oral Ticagrelor: Full Report of the PACIFY Randomized Clinical Trial.

Authors:  Khalil Ibrahim; Rohan Shah; Rakesh R Goli; Thomas S Kickler; William A Clarke; Rani K Hasan; Roger S Blumenthal; David R Thiemann; Jon R Resar; Steven P Schulman; John W McEvoy
Journal:  Thromb Haemost       Date:  2018-07-04       Impact factor: 5.249

5.  The MOVEMENT Trial.

Authors:  Manne Holm; Per Tornvall; Loghman Henareh; Ulf Jensen; Nanna Golster; Patrik Alström; Irene Santos-Pardo; Nils Witt; Nikolai Fedchenko; Dimitrios Venetsanos; Olof Beck; Jan van der Linden
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

6.  Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor.

Authors:  Piotr Adamski; Katarzyna Buszko; Joanna Sikora; Piotr Niezgoda; Tomasz Fabiszak; Małgorzata Ostrowska; Malwina Barańska; Aleksandra Karczmarska-Wódzka; Eliano Pio Navarese; Jacek Kubica
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

7.  Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial.

Authors:  Moazez J Marian; Hussein Abu Daya; Arka Chatterjee; Firas Al Solaiman; Mark F Sasse; William S Fonbah; Raymond W Workman; Brittany E Johnson; Sarah E Carlson; Brigitta C Brott; Sumanth D Prabhu; Massoud A Leesar
Journal:  J Am Heart Assoc       Date:  2019-11-26       Impact factor: 5.501

8.  Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y12 signaling pathway.

Authors:  Bo Huang; Yufeng Qian; Shujun Xie; Xianhua Ye; Hanwen Chen; Zhifeng Chen; Lihuan Zhang; Jinming Xu; Hu Hu; Shenglin Ma; Paul Héroux; Di Wang; Han-Ming Shen; Yihua Wu; Dajing Xia
Journal:  Cell Mol Immunol       Date:  2020-06-10       Impact factor: 11.530

Review 9.  The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.

Authors:  Ying Han; Wei Yan; Yongbo Zheng; Muhammad Zahid Khan; Kai Yuan; Lin Lu
Journal:  Transl Psychiatry       Date:  2019-11-11       Impact factor: 6.222

10.  Sex-Specific Platelet Activation Through Protease-Activated Receptors Reverses in Myocardial Infarction.

Authors:  Beom Soo Kim; David S Auerbach; Hamza Sadhra; Matthew Godwin; Rohan Bhandari; Frederick S Ling; Amy Mohan; David I Yule; Larry Wagner; David Q Rich; Sara Ture; Craig N Morrell; Livia Timpanaro-Perrotta; Arwa Younis; Ilan Goldenberg; Scott J Cameron
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-11-12       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.